Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lena Lemke, MD
CatalYm GmbH
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Esslingen Gmbh
Esslingen am Neckar, Baden-Wurttemberg, Germany
Recruiting - University Hospital Wuerzburg, Clinic and Polyclinic Ii for Gastroenterology, Hematology, Internal Oncology, Stem Cell Therapies, Hepatology, Infectiology, Psychosomatics and Rheumatology/ Clinical Immunology
Würzburg, Bavaria, Germany
Recruiting - Evangelical Hospital Bethel, Clinic for Internal Medicine, Hematology/oncology, Palliative Medicine Johannesstift
Bielefeld, North Rhine-Westphalia, Germany
Recruiting - Clinics Essen-Mitte
Essen, North Rhine-Westphalia, Germany
Recruiting - Foundation Bethanien Moers
Moers, North Rhine-Westphalia, Germany
Recruiting
- Institute of Romagna for Cancer Research "dino Amadori" - Irccs Irst
Forlì, Emilia-Romagna, Italy
Recruiting - Oncology Reference Center
Aviano, Friuli Venezia Giulia, Italy
Recruiting - National Cancer Institute Regina Elena, Irccs
Rome, Lazio, Italy
Recruiting - Local Health Unit of Romagna - Santa Maria Delle Croci Hospital of Ravenna, Onco-Hematology Department
Ravenna, Italy
Recruiting
- Sf. Nectarie Oncology Center
Craiova, Dolj, Romania
Recruiting - Clinica Polisano S.R.L
Sibiu, Sibiu County, Romania
Recruiting - Sc Oncomed Srl
Timișoara, Timiș County, Romania
Recruiting
- University Hospital of Jaen
Jaén, Andalusia, Spain
Recruiting - Regional University Hospital of Malaga
Málaga, Andalusia, Spain
Recruiting - University Hospital Complex of Santiago (chus)
Santiago de Compostela, Galicia, Spain
Recruiting - Start- Rioja
Logroño, La Rioja, Spain
Recruiting - University Hospital 12 de Octubre
Madrid, Madrid, Spain
Recruiting - University Hospital Hm Sanchinarro
Madrid, Madrid, Spain
Recruiting - University Hospital Lucus Augusti (hula)
Lugo, Spain
Recruiting
- University Hospital Basel
Basel, Switzerland
Recruiting - Cantonal Hospital Saint Gallen, Clinic of Oncology and Hematology
Sankt Gallen, Switzerland
Recruiting
- University of Alabama at Birmingham (o'Neal Comprehensive Cancer Center)
Birmingham, Alabama, United States
Recruiting - Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
Recruiting - Nyu Longone Health
New York, New York, United States
Recruiting - Duke University Medical Center
Durham, North Carolina, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Oct 2025
- Primary completion
- 1 Oct 2029
- Completion
- 1 Oct 2031
- Last update posted
- 9 Jun 2026
- Registered enrollment
- 131
- Registry id
- NCT07246863
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.